The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress
Abstract
Background— Circulating levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) are elevated in diabetic patients. We assessed the role of glucose in the regulation of circulating levels of IL-6, TNF-α, and interleukin-18 (IL-18) in subjects with normal or impaired glucose tolerance (IGT), as well as the effect of the antioxidant glutathione. Methods and Results— Plasma glucose levels were acutely raised in 20 control and 15 IGT subjects and maintained at 15 mmol/L for 5 hours while endogenous insulin secretion was blocked with octreotide. In control subjects, plasma IL-6, TNF-α, and IL-18 levels rose ( P <0.01) within 2 hours of the clamp and returned to basal values at 3 hours. In another study, the same subjects received 3 consecutive pulses of intravenous glucose (0.33 g/kg) separated by a 2-hour interval. Plasma cytokine levels obtained at 3, 4, and 5 hours were higher ( P <0.05) than the corresponding values obtained during the clamp. The IGT subjects had fasting plasma IL-6 and TNF-α levels higher ( P <0.05) than those of control subjects. The increase in plasma cytokine levels during the clamping lasted longer (4 hours versus 2 hours, P <0.01) in the IGT subjects than in the control subjects, and the cytokine peaks of IGT subjects after the first glucose pulse were higher ( P <0.05) than those of control subjects. On another occasion, 10 control and 8 IGT subjects received the same glucose pulses as above during an infusion of glutathione; plasma cytokine levels did not show any significant change from baseline after the 3 glucose pulses. Conclusions— Hyperglycemia acutely increases circulating cytokine concentrations by an oxidative mechanism, and this effect is more pronounced in subjects with IGT. This suggests a causal role for hyperglycemia in the immune activation of diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, a negative influence of postprandial hypertriglyceridemia on endothelial function has been reported in both normal and diabetic subjects.”
In the citing paper
“Other studies have demonstrated that fluctuations in blood glucose levels may contribute more to outcomes than constant high blood glucose concentrations.31–35”
From Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen (2020) · cites this paper as [32]
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,246
Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.101.18.2149 · Cited by 934
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Cited by
Sorted by citations
Items 101–200 of 1,003
Cell Death and Diabetic Cardiomyopathy
Cai, L., & Kang, Y. J. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:3:219 · Cited by 199
“An inflammatory response commonly occurs in the diabetic subjects, resulting in a significant increase in various cytokines (53).”
BackgroundEffects of Periodontal Therapy on Glycemic Control and Inflammatory Markers
O'Connell, P. A., Taba, M., Nomizo, A., Foss‐Freitas, M. C., Suaid, F. A., Uyemura, S. A., Trevisan, G. L., Novaes, A. B., de Souza, S. L. S., Palioto, D. B., et al. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070250 · Cited by 206
Hyperglycemia and morbidity and mortality in extremely low birth weight infants
Kao, L. S., Morris, B. H., Lally, K. P., Stewart, C. D., Huseby, V., & Kennedy, K. A. (2006) · Journal of Perinatology · doi:10.1038/sj.jp.7211593 · Cited by 199
Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis
Brennan, A. L., Gyi, K. M., Wood, D. M., Johnson, J., Holliman, R., Baines, D. L., Philips, B. J., Geddes, D. M., Hodson, M. E., & Baker, E. H. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.009 · Cited by 198
Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype
Berenbaum, F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146399 · Cited by 197
Piconi, L., Quagliaro, L., ROS, R. D., Assaloni, R., Giugliano, D., Esposito, K., Szabó, C., & Ceriello, A. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00835.x · Cited by 198
Self-citationAntioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Ceriello, A., & Testa, R. (2009) · Diabetes Care · doi:10.2337/dc09-s316 · Cited by 200
“However, patients with impaired glucose tolerance had significantly higher tumor necrosis factor- and IL-6 at baseline levels, and cytokine levels reached substantially higher peaks and stayed elevated for considerably longer than in the control subjects (13).”
InfluentialSelf-citationAnti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy
Bhatt, K. S., Lanting, L. L., Jia, Y., Yadav, S., Reddy, M. A., Magilnick, N., Boldin, M., & Natarajan, R. D. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010111 · Cited by 198
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 202
Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta‐analysis
Pourmemari, M., & Shiri, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12855 · Cited by 195
Effects of Stress Hyperglycemia on Acute Myocardial Infarction
Marfella, R., Siniscalchi, M., Esposito, K., Sellitto, A., Fanis, U. D., Romano, C. P., Portoghese, M., Siciliano, S., Nappo, F., Sasso, F. C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3129 · Cited by 192
Self-citationBlood glucose variability is associated with mortality in the surgical intensive care unit
Dossett, L. A., Cao, H., Mowery, N. T., Dortch, M. J., Morris, J. M., & May, A. K. (2008) · The American Surgeon™ · doi:10.1177/000313480807400802 · Cited by 190
Postprandial metabolic events and fruit-derived phenolics: a review of the science
Burton‐Freeman, B. M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003909 · Cited by 190
Guideline for management of postmeal glucose in diabetes
1 (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.002 · Cited by 185
Postprandial Hyperglycemia and Glycemic Variability
Standl, E., Schnell, O., & Ceriello, A. (2011) · Diabetes Care · doi:10.2337/dc11-s206 · Cited by 183
“The role of oxidative stress also seems to be a key causative factor clinically because the use of an antioxidant reduced the phenomenon in both the studies (51).”
BackgroundSelf-citationNilsson, A. C., OÖstman, E. M., Granfeldt, Y. E., & Björck, I. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.3.645 · Cited by 181
Postprandial hyperglycemia as an etiological factor in vascular failure
Node, K., & Inoue, T. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-23 · Cited by 183
“The concept of atherosclerosis as an inflammatory disease, even in diabetes, is now well established [41], with evidence that acute hyperglycemia during either a hyperglycemic clamp [42] or the postprandial state [43] increases production of plasma interleukin-6, tumor necrosis factor-α and interleukin-18.”
BackgroundChan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 186
“Experimental evidence in humans demonstrated that hyperglycaemia stimulates pro-inflammatory cytokines, including TNF-α, IL-6 and IL-18 in the circulation (Esposito et al., 2002).”
BackgroundDandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.003 · Cited by 180
Lutchmansingh, F., Hsu, J. W.-C., Bennett, F. I., Badaloo, A. V., McFarlane‐Anderson, N., Gordon-Strachan, G. M., Wright-Pascoe, R. A., Jahoor, F., & Boyne, M. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198626 · Cited by 187
Engebretson, S. P., Hey‐Hadavi, J., Ehrhardt, F. J., Hsu, D., Celenti, R. S., Grbic, J. T., & Lamster, I. B. (2004) · Journal of Periodontology · doi:10.1902/jop.2004.75.9.1203 · Cited by 182
Talior‐Volodarsky, I., Yarkoni, M., Bashan, N., & Eldar-Finkelman, H. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00044.2003 · Cited by 180
“It should be noted, however, that our studies do not eliminate the role of additional in vivo factors such as hyperinsulinemia, hyperlipidemia, and adipocytokines that could contribute to the increased oxidative stress during the HF diet feeding period, as these factors were shown to elevate ROS levels in various cell…”
BackgroundGlucose variability: An emerging target for the treatment of diabetes mellitus
Frontoni, S., Bartolo, P. D., Avogaro, A., Bosi, E., Paolisso, G., & Ceriello, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.007 · Cited by 176
“Endothelial dysfunction is generated by glucose oscillations, both in normal subjects and in patients with T2DM, and the use of an antioxidant prevents this effect [58].”
BackgroundSelf-citationProspective study of dietary patterns and chronic obstructive pulmonary disease among US men
Varraso, R., Fung, T. T., Hu, F. B., Willett, W. C., & Camargo, C. A. (2007) · Thorax · doi:10.1136/thx.2006.074534 · Cited by 178
Barrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., Scacchi, M., Orio, F., Aimaretti, G., Colao, A., & Savastano, S. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000136 · Cited by 171
“Esposito et al.((46)) reported that hyperglycaemic spikes are able to affect cytokine concentrations more than continuous hyperglycaemia, at least in the short term, suggesting that an oxidative mechanism could mediate the effect of hyperglycaemia.”
Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes
Bessueille, L., & Magne, D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1876-4 · Cited by 182
Gestational Diabetes After Delivery
Kitzmiller, J. L., Dang-Kilduff, L., & Taslimi, M. M. (2007) · Diabetes Care · doi:10.2337/dc07-s221 · Cited by 179
Higher normal fasting plasma glucose is associated with hippocampal atrophy
Cherbuin, N., Sachdev, P. S., & Anstey, K. J. (2012) · Neurology · doi:10.1212/wnl.0b013e31826846de · Cited by 170
Insulin as an Anti-Inflammatory and Antiatherogenic Modulator
Dandona, P., Chaudhuri, A., Ghanim, H., & Mohanty, P. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.038 · Cited by 173
“(4) demnstrated that the induction of steady-state hyperglycemia ith intravenous glucose infusion with concomitant inhibiion of endogenous insulin secretion with somatostatin led o an increase in plasma tumor necrosis factor-alpha and nterleukin-6 concentrations.”
BackgroundInterleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
Zorrilla, E. P., Sánchez-Alavez, M., Sugama, S., Brennan, M., Fernandez, R. E., Bartfai, T., & Conti, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611523104 · Cited by 170
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Bleve, A., Motta, F., Durante, B., Pandolfo, C., Selmi, C., & Sica, A. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08909-7 · Cited by 185
Inflammatory and endothelial markers in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168
Czernichow, S., Vergnaud, A., Galan, P., Arnaud, J., Favier, A. E., Faure, H., Huxley, R., Herçberg, S., & Ahluwalia, N. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27635 · Cited by 166
Wu, N., Shen, H., Liu, H., Wang, Y., Bai, Y. Z., & Han, P. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0427-0 · Cited by 166
“[51] also found that fluctuant hyperglycemia could induce TNF-α production in the blood of human in vivo.”
BackgroundJacka, F. N., Cherbuin, N., Anstey, K. J., & Butterworth, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087657 · Cited by 161
“Animal studies have shown that rodents fed a high fat diet had higher level of neuronal inflammation [34], while in humans, experimentally raised plasma glucose levels were associated with increased plasma cytokine (TNF-a, IL6, IL18) [35].”
BackgroundHigh-density lipoproteins, inflammation and oxidative stress
Tabet, F., & Rye, K. (2008) · Clinical Science · doi:10.1042/cs20080106 · Cited by 165
de Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000215951.36219.a4 · Cited by 163
Gut microbiota and probiotics: Focus on diabetes mellitus
Tonucci, L. B., dos Santos, K. M. O., Ferreira, C. L. D. L. F., Ribeiro, S. M. R., de Oliveira, L. L., & Martino, H. S. D. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.934438 · Cited by 168
“The major cytokines that are related to glycemic control are tumor necrosis factor-a (TNF-a), IL-6, resistin, adiponectin, and IL-10 (Pickup et al., 2000; Esposito et al., 2002; Spranger et al., 2003; Wang et al., 2013).”
BackgroundEchouffo-Tcheugui, J. B., Zhao, S., Brock, G. N., Matsouaka, R., Kline, D., & Joseph, J. J. (2019) · Diabetes Care · doi:10.2337/dc18-1430 · Cited by 162
“While prior studies have focused on people with diabetes (4,5), there is robust evidence to suggest that the pathophysiological changes associated with glycemic fluctuations compared with stable glucose levels, including higher levels of inflammatory cytokines and the resulting endothelial dysfunction, are manifest in…”
BackgroundDiabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Fève, B., Ferré, P., Halimi, S., Baïzri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 167
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
“TNF-a is also involved in oxidative stress and mitochondrial dysfunction and endoplasmic reticulum stress [144, 145].”
BackgroundNorth, C., Venter, C. S., & Jerling, J. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.8 · Cited by 158
Aljada, A., Friedman, J., Ghanim, H., Mohanty, P., Hofmeyer, D., Chaudhuri, A., & Dandona, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.016 · Cited by 161
Anti‐Inflammatory Diet in Clinical Practice: A Review
Ricker, M., & Haas, W. C. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617700353 · Cited by 169
“Regular consumption of high glycemic–load carbohydrates results in chronic hyperglycemia, which, through varying mechanisms, increases the production of free radicals and proinflammatory cytokines.(5,6) In attempt to reduce elevations of blood glucose, the pancreas secretes insulin.”
BackgroundHsieh, C., Liu, C., Lee, C., Yu, L.-E., & Wang, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37215-0 · Cited by 159
Ramteke, P. L., Deb, A., Shepal, V., & Bhat, M. K. (2019) · Cancers · doi:10.3390/cancers11091402 · Cited by 157
“Inflammatory markers like NFKB, TNF-α, IL-6, and IL-18 levels were elevated in hyperglycemic patients [76–79].”
BackgroundInfluentialThe role of interleukin-18 in the metabolic syndrome
Trøseid, M., Seljeflot, I., & Arnesen, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-11 · Cited by 155
“ing levels of IL-18 [51].”
Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature
Gläser, S., Krüger, S., Merkel, M., Bramlage, P., & Herth, F. J. F. (2015) · Respiration · doi:10.1159/000369863 · Cited by 152
Bench-to-bedside review: Glucose and stress conditions in the intensive care unit
Losser, M.-R., Damoisel, C., & Payen, D. M. (2010) · Critical Care · doi:10.1186/cc9100 · Cited by 153
“In healthy volunteers, hyperglycaemic spikes induced increased pro-infl ammatory cytokine levels that were blunted by antioxidant pretreatment [ 117 ].”
Caballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151
Timmer, J. R., Ottervanger, J. P., de Boer, M., Dambrink, J. E., Hoorntje, J. C. A., Gosselink, A. T. M., Suryapranata, H., Zijlstra, F., & Hof, A. W. J. V. ’. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.12.050 · Cited by 150
Vriesendorp, T. M., Morélis, Q. J., DeVries, J. H., Legemate, D. A., & Hoekstra, J. B. L. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.08.006 · Cited by 150
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
Bruun, J. M., Stallknecht, B. M., Helge, J. W., & Richelsen, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0206 · Cited by 152
“These findings may suggest that plasma IL-18 is more related to the degree of insulin sensitivity/insulin resistance than to obesity per se. Recently, clamp-induced hyperglycemia (15 mmol/l) was reported to increase plasma IL-18 ( 38 ), indicating that weight loss as reported in the present study and other studies may…”
ResultEvolution of the Human Diet and Its Impact on Gut Microbiota, Immune Responses, and Brain Health
Olmo, B. M. G., Butler, M. J., & Barrientos, R. M. (2021) · Nutrients · doi:10.3390/nu13010196 · Cited by 161
“For examples, hyperglycemia has been causally linked to increases in circulating proinflammatory cytokines in human subjects with and without impaired glucose tolerance [73].”
BackgroundGlucose Control and the Inflammatory Response
Collier, B. R., Dossett, L. A., May, A. K., & Diaz, J. J. (2008) · Nutrition in Clinical Practice · doi:10.1177/011542650802300103 · Cited by 155
Marenzi, G., Cosentino, N., Milazzo, V., Metrio, M. D., Cecere, M., Mosca, S., Rubino, M., Campodonico, J., Moltrasio, M., Marana, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1732 · Cited by 151
“Acute hyperglycemia results in a prothrombotic state, modulates inflammatory response and oxidative stress, and is the cause of endothelial dysfunction and impaired microcirculatory function (5–7), leading to larger infarct size (8,9).”
BackgroundInsulin infusion in acute illness
Dandona, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26045 · Cited by 147
Englund‐Ögge, L., Brantsæter, A. L., Haugen, M., Sengpiel, V., Khatibi, A., Myhre, R., Myking, S., Meltzer, H. M., Kacerovský, M., Nilsen, R. M., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.031567 · Cited by 146
Aragno, M., Mastrocola, R., Medana, C., Catalano, M. G., Vercellinatto, I., Danni, O., & Boccuzzi, G. (2006) · Endocrinology · doi:10.1210/en.2006-0728 · Cited by 147
Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarction
Ceriello, A. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi049 · Cited by 148
Self-citationGonzález, Y., Herrera, M. T., Soldevila, G., García‐García, L., Fabián, G., Pérez-Armendáriz, E. M., Bobadilla, K., Guzmán‐Beltrán, S., Sada, E., & Torres, M. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-19 · Cited by 149
“Background Both acute and chronic hyperglycemia are associated with inflammation [1].”
BackgroundNrf2 Suppression Delays Diabetic Wound Healing Through Sustained Oxidative Stress and Inflammation
Li, M., Yu, H., Pan, H., Zhou, X., Ruan, Q., Kong, D., Chu, Z., Li, H., Huang, J., Huang, X., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01099 · Cited by 148
Glucose metabolism in lymphoid and inflammatory cells and tissues
Calder, P. C., Dimitriadis, G., & Newsholme, P. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3281e72ad4 · Cited by 143
Rashid, K., & Sil, P. C. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.003 · Cited by 142
Sorrentino, F. S., Allkabes, M., Salsini, G., Bonifazzi, C., & Perri, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.001 · Cited by 150
“Astrocytes react becoming activated [32,33] and undergo a series of changes: proliferation, migration, hypertrophy, glial fibrillary acid protein (GFAP) expression, secretion of pro-inflammatory signals such as IL-6, MCP-1 and macrophage inflammatory protein 2 alpha (MIP-2α).”
InfluentialPostprandial Variations of Plasma Inflammatory Markers in Abdominally Obese Men
Blackburn, P., Després, J., Lamarche, B., Tremblay, A., Bergeron, J., Lemieux, I., & Couillard, C. (2006) · Obesity · doi:10.1038/oby.2006.201 · Cited by 140
“There is increasing evidence that postprandial changes in plasma glucose could be associated more closely with circulating inflammatory cytokine concentrations (40).”
BackgroundDiabesity: An Inflammatory Metabolic Condition
Schmidt, M. I., & Duncan, B. B. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.174 · Cited by 140
“Two possible pathogenic pathways involving inflammatory mechanisms are the oxidative stress (80) and the accumulation of the advanced glycosylation endproducts (AGE) (81), caused by hyperglycemia (see also Piconi et al.”
BackgroundIs Metabolic Syndrome X an Inflammatory Condition?
Das, U. N. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701106 · Cited by 140
“Esposito et al. [ 22 ] observed that when plasma glucose levels were acutely raised in control and IGT subjects and maintained at 15 mmol/L for 5 hours whereas endogenous insulin secretion was blocked with octreotide, in control subjects, plasma IL-6, TNF-α, and IL-18 levels rose, but were much lower compared with tho…”
ResultAdolfsson, P., Hartvig, N. V., Kaas, A., Møller, J. B., & Hellman, J. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0411 · Cited by 139
Glycemic control in non-diabetic critically ill patients
Farrokhi, F., Smiley, D. D., & Umpierrez, G. E. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.004 · Cited by 142
Ishihara, M., Kagawa, E., Inoue, I., Kawagoe, T., Shimatani, Y., Kurisu, S., Nakama, Y., Maruhashi, T., Ookawa, K., Dai, K., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.044 · Cited by 137
Burdge, G. C., & Calder, P. C. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041282 · Cited by 136
“Furthermore, the greater pro-inflammatory cytokine response in obese individuals and the ameliorating effect of weight loss (Esposito et al. 2002b; Giugliano et al. 2004) also suggest that adipose tissue may be the primary source of proinflammatory cytokines in the postprandial period.”
BackgroundInfluentialPrattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1810327 · Cited by 129
“hyperglycemia, also in an acute manner, through an oxidative mechanism, whose effect is more marked in subjects with impaired glucose tolerance [59].”
BackgroundSelf-citationFischer, C. P., Perstrup, L. B., Berntsen, A., Eskildsen, P. C., & Pedersen, B. K. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.07.008 · Cited by 133
Hall, N. J., Peters, M. J., Eaton, S. D., & Pierro, A. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2004.02.005 · Cited by 133
Adverse effects of hyperlipidemia on bone regeneration and strength
Pirih, F. Q. M., Lu, J., Ye, F., Bezouglaia, O., Atti, E., Ascenzi, M., Tetradis, S., Demer, L. L., Aghaloo, T. L., & Tintut, Y. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.541 · Cited by 132
Gyurko, R., Siqueira, C. C., Caldon, N., Gao, L., Kantarcı, A., & Dyke, T. E. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7250 · Cited by 133
“A similar cytokine pattern has been observed in humans, as plasma IL-6 levels are found consistently elevated in diabetic patients (31,32), whereas increased TNF-α levels were reported only after acute glucose challenge (33,34).”
BackgroundNegative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
Marfella, R., Paolisso, P., Sardu, C., Bergamaschi, L., D’Angelo, E. C., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.05.005 · Cited by 131
“In addition, it may be that hyperglycaemia impacts different components of the host response, including immune cell function and cytokine regulation [3].”
InfluentialSelf-citationDandona, P., Aljada, A., Chaudhuri, A., & Bandyopadhyay, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030178 · Cited by 129
“Hyperglycemic clamps in normal subjects, in whom endogenous insulin has been suppressed by concom- itant administration of somatostatin, induce an increase of proinflammatory cytokines, TNF and IL6 (53).”
Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
Farzaei, M. H., Singh, A. K., Kumar, R., Croley, C. R., Pandey, A. K., Coy-Barrera, E. D., Patra, J. K., Das, G., Kerry, R. G., Annunziata, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194957 · Cited by 137
“Hyperglycemia-induced oxidative stress also acutely increases pro-inflammatory cytokine levels [246].”
BackgroundActive-reset protein sensors enable continuous in vivo monitoring of inflammation
Zargartalebi, H., Mirzaie, S., GhavamiNejad, A., Ahmed, S. U., Esmaeili, F., Geraili, A., Flynn, C. D., Chang, D., Das, J., Abdrabou, A. M., et al. (2024) · Science · doi:10.1126/science.adn2600 · Cited by 138
Krogh‐Madsen, R., Møller, K., Dela, F., Kronborg, G., Jauffred, S., & Pedersen, B. K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00468.2003 · Cited by 129
“(15) found that hyperglycemia with concomitant inhibition of endogenous insulin secretion results in elevated levels of IL-6 and TNF in human volunteers, and Yu et al.”
BackgroundExercise and Type 1 Diabetes (T1DM)
Galassetti, P. R., & Riddell, M. C. (2013) · Comprehensive physiology · doi:10.1002/cphy.c110040 · Cited by 143
Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.002 · Cited by 130
Acute Hyperglycemia in Patients With Acute Myocardial Infarction
Ishihara, M. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1376 · Cited by 133
Glycemic control and infections in patients with diabetes undergoing noncardiac surgery
King, J. T., Goulet, J. L., Perkal, M. F., & Rosenthal, R. A. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181f9bb3a · Cited by 142
Walker, J., & Harrison, F. E. (2015) · Nutrients · doi:10.3390/nu7095341 · Cited by 133
“There is also evidence of chronic peripheral inflammation and increased production of pro-inflammatory cytokines [4,5], oxidative stress [6,7], and cognitive deficits [8,9].”
BackgroundEpigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Ling, C., Bacos, K., & Rönn, T. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00671-w · Cited by 138
Devaraj, S., Autret, B. C., & Jialal, I. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.756 · Cited by 125
“This is particularly important because it has been previously shown that glucose intake increases oxidative stress and glucose infusion induces inflammatory responses (20, 21); however, the reduced-calorie Sterol Bev resulted in a significant reduction in both LDL-cholesterol and CRP concentrations without affecting b…”
BackgroundBadawi, A. F. (2011) · Biologics · doi:10.2147/btt.s14417 · Cited by 129
“8,30,31 39 Given that obesity and the metabolic syndrome are steps toward the development of T2DM, their link with oxidative stress and inflammation points to a potential causative role for these factors in the progression of the disease.”
Managing Hyperglycemia in the COVID-19 Inflammatory Storm
Admin, A., Gianchandani, R., Esfandiari, N. H., ANG, L., Iyengar, J., Knotts, S., Choksi, P., & Pop-Busui, R. (2020) · Diabetes · doi:10.2337/dbi20-0022 · Cited by 128
Anti-inflammatory effects of insulin
Dandona, P., Chaudhuri, A., Mohanty, P., & Ghanim, H. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3281e38774 · Cited by 124
The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis
Mi, W., Xia, Y., & Bian, Y. (2019) · Inflammation Research · doi:10.1007/s00011-019-01220-4 · Cited by 129
Ceriello, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.020 · Cited by 124
Self-citationTschöpe, C., Walther, T., Escher, F., Spillmann, F., Du, J., Altmann, C., Schimke, I., Bäder, M., Sánchez‐Ferrer, C. F., Schultheiß, H., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-4095fje · Cited by 122
“Hyperlipoproteinemia and hyperglycemia induce several cytokines in humans, possibly by oxidative stress (31).”
BackgroundYoshida, D., Ninomiya, T., & Kiyohara, Y. (2004) · PubMed · Cited by 121
Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients
Philips, B. J. (2005) · Thorax · doi:10.1136/thx.2004.035766 · Cited by 120
“Systemic hyperglycaemia induces proinflammatory cytokine production including tumour necrosis factor α and interleukin 6, possibly due to upregulation of NF-κB,”
BackgroundGiubilato, S., Liuzzo, G., Brugaletta, S., Pitocco, D., Graziani, F., Smaldone, C., Montone, R. A., Pazzano, V., Pedicino, D., Biasucci, L. M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq499 · Cited by 119
Economides, P. A., Caselli, A., Tiani, E., Khaodhiar, L., Horton, E. S., & Veves, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031116 · Cited by 120
Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 125
“45,46 Acute stress increases proinflammatory cytokines, such as tumor necrosis factor (TNF)- α , interleukin (IL)-6, and IL-1, 34,47–49 which increase insulin resistance by interfering with insulin signaling.”
Background
Metadata
- Authors
- Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D.
- Affiliations
- University of Udine (IT)
- Venue
- Circulation
- Published
- 2002-10-15
- Volume
- 106
- Issue
- 16
- Pages
- 2067-2072
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2123560318
- Cited by
- 1,961
- References
- 36
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 88 · 2023: 95 · 2022: 106 · 2021: 91 · 2020: 102 · 2019: 83 · 2018: 86 · 2017: 70 · 2016: 87 · 2015: 112 · 2014: 99 · 2013: 102 · 2012: 101
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, inflammatory cytokines, interleukin-6, TNF-α, IL-18, impaired glucose tolerance, glutathione, oxidative stress, glucose clamp
- MeSH terms
- Adult, Antioxidants, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glutathione, Humans, Inflammation, Kinetics, Male, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Glucose Intolerance, Oxidative Stress, Interleukin-18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
